Genius Biotherapeutics

Tel: +27 21 427 1400
Fax: +27 21 419 0731

Genius Biotherapeutics (formerly Bioclones (Pty) Ltd)

Genius was established in 1982, and is arguably the oldest health care biotechnology company in South Africa, if not the African continent, with a track record of investing in research and development work that led to successfully commercialising South Africa’s first biosimilar product Repotin, a recombinant human hormone known as erythropoietin (EPO). Genius is a research and development biopharmaceutical group of companies that produce:

  • Immunotherapy dendritic cell vaccine technology (DCV)
  • Erythropoietin production registered as Repotin
  • Granulocyte-colony stimulating factor (G-CSF) product development
  • Integrated Bioworks (IBW) – Producing laboratory reagents – MMLV Reverse Transcriptase (RT) – Additional lab consumables
  • Other niche products – Peptide cream